BackGalera Therapeutics Overview
Galera Therapeutics Inc

Galera Therapeutics Discounted Cash Flow

DCF Analysis for GRTX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.06

Current Fair Value

$0.06
25.7% Downside

Overvalued by 25.7% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading